Voyager Therapeutics (VYGR) Net Margin Growth (5y) (2020 - 2026)
Powered by 
Analysis
Voyager Therapeutics (VYGR) Net Margin Growth (5y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Voyager Therapeutics | 195.27 Mn | 78.93 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 134,192.00 |
| Mar 31, 2026 | -68,105.00 |
| Dec 31, 2025 | 22,919.00 |
| Sep 30, 2025 | -28,080.00 |
| Jun 30, 2025 | -60,969.00 |
| Mar 31, 2025 | -34,492.00 |
| Dec 31, 2024 | -51,085.00 |
| Sep 30, 2024 | 3,672.00 |
| Jun 30, 2024 | -5,846.00 |
| Mar 31, 2024 | 46,475.00 |
| Dec 31, 2023 | 118,468.00 |
| Sep 30, 2023 | 40,755.00 |
| Jun 30, 2023 | 53,866.00 |
| Mar 31, 2023 | 219,772.00 |
| Dec 31, 2022 | 171,017.00 |
| Sep 30, 2022 | 207,652.00 |
| Jun 30, 2022 | -107,702.00 |
| Mar 31, 2022 | -210,281.00 |
| Dec 31, 2021 | 64,159.00 |
| Sep 30, 2021 | -142,421.00 |